The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fluvoxamine maleate extended-release
Fluvoxamine maleate extended-release · FLUVOXAMINE MALEATE 100 mg/1 · Capsule, Extended Release · Oral · Zydus Pharmaceuticals USA Inc.
NDC 70710-1847-03 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for fluvoxamine maleate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA220447
- TE code
- AB
- Approval date
- Jul 21, 2026
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fluvoxamine maleate extended-release (Capsule, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Zydus Lifesciences Limited | FLUVOXAMINE MALEATE 100 mg/1 | Aug 5, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | FLUVOXAMINE MALEATE 150 mg/1 | Aug 5, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | FLUVOXAMINE MALEATE 100 mg/1 | Aug 5, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | FLUVOXAMINE MALEATE 150 mg/1 | Aug 5, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fluvoxamine maleate extended-release — NDC 70710-1847-03," retrieved September 3, 2026, https://drugdashboards.com/drug/70710184703.
Free to cite with attribution — see how the data is put together.